Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. GEN Edge spoke with Synthekine CEO Debanjan Ray about how the company is growing an initial set of licensed cytokine programs and platforms into a clinical-stage pipeline and proprietary combinatorial engineering platform . . .
Home Therapeutics Autoimmune Disease Drugs One of a ‘Kine’: Synthekine Engineers Cytokine Therapeutics to Treat Cancer and...

One of a ‘Kine’: Synthekine Engineers Cytokine Therapeutics to Treat Cancer and Inflammatory Disease
The engineered cytokine therapeutics company designs new molecules that harness core immunomodulatory activities while minimizing their undesired properties for unmet medical needs
Interleukin (pink) binding to its receptor (dark and light blue). The receptors are shown embedded in a cell membrane (blue and orange) - Science Photo Library